Immunogenicity and Safety of 2 Doses of Live Attenuated Varicella Vaccine

NCT02173899 · clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
716
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Changchun Keygen Biological Products Co., Ltd.

Collaborators